£5m in funding support allocated to dental technology aimed at preventing tooth decay

Scottish Startup Secures £5 Million to Revolutionize Dental Healthcare in US Market

Scottish startup Calcivis has secured £5 million in funding to bring its innovative dental technology to the US market. The funding round was led by the Scottish National Investment Bank, which provided £4 million, along with an additional £1 million from IFS Maven Equity Finance managed by Maven Capital Partners.

Founded in 2012 by CEO Adam Christie and CTO Bruce Vernon, Calcivis’ imaging system uses a biologic diagnostic to enable preventative treatment of tooth decay before it becomes irreversible. The company plans to launch its product in the US first, followed by subsequent launches in the UK and other European markets.

Adam Christie emphasized the importance of early diagnosis and treatment of tooth decay, highlighting the potential for the technology to revolutionize preventive oral healthcare. According to the World Health Organization, cavities affect over two billion people worldwide, underscoring the need for innovative solutions like Calcivis.

Paul Callaghan, investment director at the Scottish National Investment Bank, praised Calcivis for its cutting-edge technology that enhances health and wellbeing. He expressed pride in supporting the company’s expansion into international markets, creating job opportunities in Scotland. The bank sees Calcivis’ technology as aligned with its innovation mission and anticipates significant health benefits for people in Scotland from the product’s launch in the UK.

Calcivis’ flagship product is an imaging system that uses a biologic diagnostic to detect tooth decay at an early stage. This allows dentists to provide preventative treatment before decay becomes irreversible, saving patients from expensive and painful procedures down the line.

The company was founded by CEO Adam Christie and CTO Bruce Vernon in 2012 with a mission to revolutionize preventive oral healthcare through innovative technology. Their flagship product is a game-changer in dental care, providing an effective solution for early detection of tooth decay.

The funding round was led by the Scottish National Investment Bank, which provided £4 million alongside an additional £1 million from IFS Maven Equity Finance managed by Maven Capital Partners. This funding will allow Calcivis to expand into new markets beyond Scotland.

The company plans to launch its product first in the US market following premarket approval from the FDA. Subsequent launches are planned for Europe and other markets.

Adam Christie highlighted

Leave a Reply

Downtown Orrville Business Seeks Permission to Offer Tattoo Services in Salon Previous post Semi-Permanent Freckle Tattoos: Natural Beauty or ‘Tramp Stamps’?
Creating a Greener Grid with Grid-Forming Inverter Technology: An Infographic Next post Transforming Power Systems: Navigating the Shift to Grid-Forming Inverters with Real-Time Insights